Loading
institutionsInstitution
National Cancer Center of China
The National Cancer Center is the body that counts China's cancers, sets national screening and quality programmes and publishes the country's official cancer statistics.
Also called: NCC China国家癌症中心National Central Cancer Registry of China
Overview
Established in 2011 and hosted by the Cancer Hospital of the Chinese Academy of Medical Sciences, the National Cancer Center runs the National Central Cancer Registry (more than 700 population-based registries), the Cancer Screening Program in Rural China and urban screening programmes, national quality control for cancer care, and the Journal of the National Cancer Center. Its 2024 report estimated about 4.8 million new cases and 2.6 million deaths in 2022 (age-standardised incidence 201.61 and mortality 96.47 per 100,000), with lung, colorectal, thyroid, liver and stomach cancers making up 57.42% of cases and mortality rates falling about 1.3% a year since 2000.
Location
Beijing, CN
Type
government
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#477 · 8 points (0 Newsweek + 0 NCI + 8 from 4 linked objects) · ranking
- National Central Cancer Registry
- Cancer Screening Program in Rural China
- National cancer quality control
- Journal of the National Cancer Center
observationalJournal of the National Cancer Center 20242,302 citations
Cancer incidence and mortality in China, 2022
One institution page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observationalCA: A Cancer Journal for Clinicians 201613,601 citations
Chen 2016: Cancer statistics in China, 2015
China accounts for roughly a quarter of the world's cancer cases, and this paper is the reference that made its burden legible internationally. It explains why Chinese trial programmes and drug pipelines concentrate on lung, stomach, oesophageal and liver cancers.
Similar pages
- PersonZhu Chen
Shares National Healthcare Security Administration and the tag china.
- InstitutionInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Shares Cancer Hospital, Chinese Academy of Medical Sciences and the tag china.
- TrialDAWNA-1
Shares Cancer Hospital, Chinese Academy of Medical Sciences and the tag china.
- TrialORIENT-11
Shares National Medical Products Administration / Center for Drug Evaluation and the tag china.
- TreatmentMecapegfilgrastim
Shares National Medical Products Administration / Center for Drug Evaluation and the tag china.
- TermChina National Reimbursement Drug List negotiation and volume-based procurement
Shares National Healthcare Security Administration, National Medical Products Administration / Center for Drug Evaluation.
- IdeaAn open global model of cancer workforce supply and demand by country
Shares International Agency for Research on Cancer (IARC / WHO), Data silos.
- IdeaOpen-source cancer registry-in-a-box for low-resource settings
Shares International Agency for Research on Cancer (IARC / WHO), Data silos.